QUIANA DUNCAN: Open Payments
NPI 1932513314 · LINCOLNTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,770 in 109 payments from 14 companies in 2025. Trend: 2023 $53 · 2024 $1,779 · 2025 $1,770
Food & beverage: $1,770
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $327 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $296 |
| AstraZeneca Pharmaceuticals LP | 11 | $291 |
| Abbott Laboratories | 25 | $230 |
| PFIZER INC. | 10 | $141 |
| Novo Nordisk Inc | 9 | $135 |
| GlaxoSmithKline, LLC. | 4 | $97 |
| Lilly USA, LLC | 3 | $62 |
| Exact Sciences Corporation | 2 | $42 |
| Amgen Inc. | 3 | $42 |
Products named: CAPLYTA, VRAYLAR, FREESTYLE LIBRE 3, AIRSUPRA, NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, Ozempic.
Industry payments across NC — which companies pay providers there.
